EF1502 is a novel, potent and selective GAT1/BGT1 inhibitor that exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.

纯度：≥98%

CAS：684645-54-3